{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T10:38:39Z","timestamp":1776767919578,"version":"3.51.2"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>This study investigated the pathological characteristics and risk factors of early cardiovascular disease (CVD) associated with rheumatoid arthritis (RA) using a collagen-induced arthritis (CIA) rat model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 120 SPF-grade male SD rats were used. Following CIA induction, echocardiography, histopathology, molecular biology, and lipid profile analysis were employed to dynamically monitor cardiac function, structural changes, and lipid profiles across disease stages (D0-D112) .<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sequential progression of cardiac dysfunction: Echocardiography revealed a significant decrease in the mitral valve E\/A ratio (MVE\/A) starting from D84 (P&amp;lt;0.05), indicating diastolic impairment preceding systolic dysfunction.Myocardial structural abnormalities: The heart-to-body weight ratio (HW\/BW) in CIA rats was significantly higher than that in the control group starting from day 84 (*P &amp;lt; 0.01), indicating cardiac hypertrophy. Masson staining revealed progressive myocardial fibrosis with increasing collagen deposition from D56. Abnormal lipid profiles and biomarkers: LDL-C significantly increased from D84 to D112 (*P&amp;lt;0.01), while OX-LDL rose from D98 to D112 (P&amp;lt;0.05); B-type natriuretic peptide (BNP) significantly increased at D112 (*P&amp;lt;0.01), indicating heart failure risk. Negative atherosclerosis findings: No plaque formation was detected in the Oil Red O staining of the aorta and coronary arteries. While macroscopic atherosclerotic plaques were not apparent, microvascular endothelial dysfunction may play a role in the early stages of cardiovascular disease (CVD) .<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Cardiovascular lesions in CIA rats exhibit sequential progression: diastolic dysfunction and myocardial fibrosis emerge first (from D56), followed by systolic dysfunction (from D98), accompanied by lipid metabolism disorders driven by LDL-C and OX-LDL. This model provides an experimental basis for studying the mechanisms of RA-associated cardiac lesions and early intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1801144","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T09:41:42Z","timestamp":1776764502000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["An experimental study of early cardiovascular disease and risk factors in a collagen-induced arthritis rat model"],"prefix":"10.3389","volume":"17","author":[{"given":"Chun Yun","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengtao","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Run","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key013","article-title":"Rheumatoid arthritis and excess mortality: down but not out. A primary care cohort study using data from Clinical Practice Research Datalink","volume":"57","author":"Abhishek","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw018","article-title":"Coronary microvascular dysfunction in chronic inflammatory rheumatic diseases","volume":"37","author":"Faccini","year":"2016","journal-title":"Eur Heart J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.007740","article-title":"Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity","volume":"63","author":"Vaudo","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-018-0022-8","article-title":"Microvascular endothelial dysfunction in rheumatoid arthritis","volume":"14","author":"Bordy","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00059-015-4320-5","article-title":"Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study","volume":"40","author":"Cioffi","year":"2015","journal-title":"Herz"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21861","article-title":"Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic review","volume":"65","author":"Aslam","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/08923973.2018.1434793","article-title":"Experimental animal models of rheumatoid arthritis","volume":"40","author":"Choudhary","year":"2018","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200002)43:2<320::AID-ANR11>3.0.CO;2-9","article-title":"Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of collagen-induced arthritis","volume":"43","author":"Cuzzocrea","year":"2000","journal-title":"Arthritis Rheum"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200726","article-title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"71","author":"Avina-Zubieta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-023-08975-z","article-title":"Tumor Necrosis Factor Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis","volume":"65","author":"Luciano","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.102.9.1000","article-title":"Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease","volume":"102","author":"Fichtlscherer","year":"2000","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13040870","article-title":"New cardiovascular risk biomarkers in rheumatoid arthritis: implications and clinical utility-a narrative review","volume":"13","author":"Pamies","year":"2025","journal-title":"Biomedicines"},{"key":"B13","article-title":"Cardiovascular disease in patients with inflammatory rheumatic diseases is associated with upregulation of cardiac microvascular and myocardial inflammatory markers","volume":"62","author":"Grundtman","year":"2010","journal-title":"J Rheumatol"},{"key":"B14","article-title":"Cardiac magnetic resonance evaluation of myocarditis-pericarditis as a first manifestation of rheumatoid arthritis relapse","volume":"12","author":"Mavrogeni","year":"2013","journal-title":"Targets Drug Dev Inflammation Allergy"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw208","article-title":"Systemic inflammation and arrhythmia risk: insights from rheumatoid arthritis","volume":"38","author":"Lazzerini","year":"2017","journal-title":"Eur Heart J"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e014661","DOI":"10.1161\/JAHA.119.014661","article-title":"Heart Failure Risk Associated With Rheumatoid Arthritis-Related Chronic Inflammation","volume":"9","author":"Ahlers","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.12.033","article-title":"Association Between Rheumatoid Arthritis and Risk of Ischemic and Nonischemic Heart Failure","volume":"69","author":"Mantel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.03.004","article-title":"Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: Association with vitamin D and inflammation","volume":"271","author":"Lo Gullo","year":"2018","journal-title":"Atherosclerosis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/art.40771","article-title":"Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography, Is Associated With Disease Activity in Rheumatoid Arthritis","volume":"71","author":"Amigues","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2174\/1871528111312030008","article-title":"Myopericarditis, as the first sign of rheumatoid arthritis relapse, evaluated by cardiac magnetic resonance","volume":"12","author":"Mavrogeni","year":"2013","journal-title":"Inflamm Allergy Drug Targets"},{"key":"B22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13075-016-1077-z","article-title":"Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis","volume":"18","author":"Meissner","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/rheumatology\/kem202","article-title":"Systemic inflammation as a risk factor for atherosclerotic thrombosis","volume":"47","author":"van Leuven","year":"2008","journal-title":"Rheumatol (Oxford)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1177\/0973369820070403","article-title":"Disease activity and lipid levels in rheumatoid arthritis: a prospective study","volume":"2","author":"Hadda","year":"2007","journal-title":"Int J Rheumatol"},{"key":"B25","article-title":"Prevalence of dyslipidemia in autoimmune rheumatic diseases","volume":"22","author":"Nisar","year":"2012","journal-title":"J Pakistan Med Surg Assoc"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.135871","article-title":"Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease","volume":"70","author":"Myasoedova","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1177\/1759720x13491025","article-title":"Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion","volume":"5","author":"van den Oever","year":"2013","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202848","article-title":"N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR)","volume":"73","author":"Mirjafari","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-023-01099-2","article-title":"Chronic \u03b2-adrenergic stress contributes to cardiomyopathy in rodents with collagen-induced arthritis","volume":"44","author":"Zhu","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04616-2","article-title":"The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk","volume":"40","author":"Venetsanopoulou","year":"2020","journal-title":"Rheumatol Int"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1159\/000524795","article-title":"Experimental atherosclerosis research on large and small animal models in vascular surgery","volume":"59","author":"Simon","year":"2022","journal-title":"J Vasc Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1801144\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T09:41:43Z","timestamp":1776764503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1801144\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":33,"alternative-id":["10.3389\/fimmu.2026.1801144"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1801144","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"article-number":"1801144"}}